Nexell Completes Split; Shares Dip
- Share via
Dow Jones
Nexell Therapeutics Inc. completed a 1-for-4 reverse stock split Thursday. Shares of the Irvine company closed at $12.88, down $2.38, in Nasdaq trading.
Shareholders approved a decrease in the number of common shares to 80 million from 160 million.
Nexell, which develops and markets cell therapies for cancer and other diseases, has 18.75 million shares of common stock outstanding.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
